A Phase 1 study of ALK201 in advanced solid tumors

Study Description

A study to evaluate the safety and effectiveness of an investigational drug called ALK201 in treating advanced solid tumors

Study Details

Registry ID:

NCT06656390

Conditions:

Advanced Cancer, Advanced Solid Tumors

Phase:

Phase 1,Phase 2

Target Enrollment:

202 participants

Start Date:

October 24, 2024

Age Range:

18–75 years

Healthy Volunteers:

No

Study Locations (38 sites)

• UCF Lake Nona Cancer Center
  Orlando, FloridaUnited States, United States
• Sarah Cannon Research Institute Oncology Partners
  Nashville, TennesseeUnited States, United States
• University Medical Center New Orleans
  New Orleans, LouisianaUnited States, United States
• Yunnan Cancer Hospital
  Kunming, YunnanChina, China
• West China Hospital of Sichuan University
  Chengdu, SichuanChina, China
• ChongQing University Cancer Hospital
  ChongqingChina, China
• Guangxi Medical University Cancer Hospital
  Nanning, GuangxiChina, China
• Denver Drug Development Unit
  Denver, ColoradoUnited States, United States
• The Central Hospital of Yongzhou
  Yongzhou, HunanChina, China
• Sun Yat-sen University Cancer Center
  Guangzhou, GuangdongChina, China
• Guangdong Province People's Hospital
  Guangzhou, GuangdongChina, China
• Hunan Cancer Hospital
  Changsha, HunanChina, China
• The First Affiliated Hospital of Henan University of Science & Technology
  Luoyang, HenanChina, China
• First Affiliated Hospital of Gannan Medical University
  Ganzhou, JiangxiChina, China
• Union Hospital, Tongji Medical College,Huazhong University of Science and Technology
  Wuhan, HubeiChina, China
• Tongji Hospital, Tongji Medical College of Hust
  Wuhan, HubeiChina, China
• Hubei Cancer Hospital
  Wuhan, HubeiChina, China
• Henan Cancer Hospital
  Zhengzhou, HenanChina, China
• Cancer Hospital Of Shantou University Medical College
  Shantou, GuangdongChina, China
• The First Affiliated Hospital Of Xiamen University
  Xiamen, FujianChina, China
• Anhui Provincial Cancer Hospital
  Hefei, AnhuiChina, China
• Fujian Medical University Union Hospital
  Fuzhou, FujianChina, China
• Fujian Cancer Hospital
  Fuzhou, FujianChina, China
• Xuzhou Central Hospital ( Southeast University Affiliated Hopstal )
  Xuzhou, JiangsuChina, China
• Shandong Cancer Hospital
  Jinan, ShandongChina, China
• Jiangsu Province Hospital
  Nanjing, JiangsuChina, China
• The First Affiliated Hospital Zhejiang University School Of Medicine
  Hangzhou, ZhejiangChina, China
• Sir Run Run Shaw Hospital Zhejiang University School of Medical
  Hangzhou, ZhejiangChina, China
• The First People's Hospital of Changzhou
  Changzhou, JiangsuChina, China
• The Second Affiliated Hospital of Soochow University
  Suzhou, JiangsuChina, China
• Affiliated Hospital of Chengde Medical University
  Chengde, HebeiChina, China
• Shanghai East Hospital
  Shanghai, Shanghai MunicipalityChina, China
• Liaoning Cancer Hospital
  Shenyang, LiaoningChina, China
• Harbin Medical University Canser Hospital
  Harbin, HeilongjiangChina, China
• Macquarie University Hospital
  MacquarieAustralia, Australia
• Cancer Care Wollongong
  Wollongong, New South WalesAustralia, Australia
• Sunshine Coast University Private Hospital
  Birtinya, QueenslandAustralia, Australia
• Mater Cancer Care Center
  South Brisbane, QueenslandAustralia, Australia

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →